In an attempt to reduce toxicity and widen the spectrum of activity of cisplatin and its analogues, much attention has been focused on designing new platinum complexes. This work reports the synthesis and characterization of novel compounds of the platinum (II) and platinum (IV) containing 2-furoic hydrazide acid and iodide as ligands. Although the prepared compounds do not present the classical structure of biologically active platinum analogues, they could be potentially active or useful as precursors to prepare antitumor platinum complexes. The reported compounds were characterized by 1H NMR, 13C NMR, 195Pt NMR, IR and elemental analyses.
Platinum(II) complexes have been used as antitumor agents since the end of XX century, when cisplati...
The first platinum-based drug was discovered and approved by Food and Drug Administration (FDA) in 1...
The synthesis of six novel cyclometallated platinum(IV) iodido complexes is accomplished by intermol...
The present work describes the synthesis of a series of platinum(IV) complexes with N-benzyl 1,3-pro...
Platinum (II) complexes, for example, cisplatin and carboplatin, have been used as chemotherapeutic ...
Platinum compounds, such as cisplatin, oxaloplatin and carboplatin, have been used as chemotherapeut...
Alguns compostos de platina (II), como por exemplo, cisplatina, carboplatina e oxaloplatina, têm sid...
The study of platinum complexes for use in chemotherapy had a big impulse in the late 60’s with disc...
Desde a descoberta da cisplatina várias tentativas têm sido feitas com o objetivo de desenvolver nov...
This work describes the synthesis, characterization and biological evaluation of novel platinum(II)...
Cancer is considered one of the main causes of death around the world. This disease can be treated u...
Cancer is considered a public health problem, accounting for about 12% of all causes of death around...
The interest in platinum(II) complexes containing S donor ligands has increased with the aim of synt...
The first platinum-based drug was discovered and approved by Food and Drug Administration (FDA) in 1...
Inspired by cisplatin, the inorganic drug discovered by Barnett Rosenberg in 1965, the research desc...
Platinum(II) complexes have been used as antitumor agents since the end of XX century, when cisplati...
The first platinum-based drug was discovered and approved by Food and Drug Administration (FDA) in 1...
The synthesis of six novel cyclometallated platinum(IV) iodido complexes is accomplished by intermol...
The present work describes the synthesis of a series of platinum(IV) complexes with N-benzyl 1,3-pro...
Platinum (II) complexes, for example, cisplatin and carboplatin, have been used as chemotherapeutic ...
Platinum compounds, such as cisplatin, oxaloplatin and carboplatin, have been used as chemotherapeut...
Alguns compostos de platina (II), como por exemplo, cisplatina, carboplatina e oxaloplatina, têm sid...
The study of platinum complexes for use in chemotherapy had a big impulse in the late 60’s with disc...
Desde a descoberta da cisplatina várias tentativas têm sido feitas com o objetivo de desenvolver nov...
This work describes the synthesis, characterization and biological evaluation of novel platinum(II)...
Cancer is considered one of the main causes of death around the world. This disease can be treated u...
Cancer is considered a public health problem, accounting for about 12% of all causes of death around...
The interest in platinum(II) complexes containing S donor ligands has increased with the aim of synt...
The first platinum-based drug was discovered and approved by Food and Drug Administration (FDA) in 1...
Inspired by cisplatin, the inorganic drug discovered by Barnett Rosenberg in 1965, the research desc...
Platinum(II) complexes have been used as antitumor agents since the end of XX century, when cisplati...
The first platinum-based drug was discovered and approved by Food and Drug Administration (FDA) in 1...
The synthesis of six novel cyclometallated platinum(IV) iodido complexes is accomplished by intermol...